Longevity Health Holdings Announces Execution Of Merger Agreement With 20/20 Biolabs
April 14 (Reuters) - Longevity Health Holdings Inc XAGE.O:
LONGEVITY HEALTH HOLDINGS ANNOUNCES EXECUTION OF MERGER AGREEMENT WITH 20/20 BIOLABS
LONGEVITY HEALTH HOLDINGS INC - COMBINED COMPANY TO TRADE ON NASDAQ UNDER SYMBOL 'XAGE'
LONGEVITY HEALTH HOLDINGS INC - POST-CLOSING EQUITY VALUATION OF COMBINED CO EXPECTED TO BE $99 MILLION
LONGEVITY HEALTH HOLDINGS INC - MERGER EXPECTED TO DOUBLE LONGEVITY'S FY 2025 REVENUE TO $7-8 MILLION
LONGEVITY HEALTH HOLDINGS INC - RAJIV SHUKLA TO REMAIN CHAIRMAN, JONATHAN COHEN TO BE APPOINTED CEO
LONGEVITY HEALTH HOLDINGS INC - MERGER EXPECTED TO CLOSE IN Q3 2025
LONGEVITY HEALTH HOLDINGS INC - 20/20 PRE-MERGER STOCKHOLDERS TO OWN 50.1% OF COMBINED COMPANY POST-MERGER
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
Citi Raises Brent Crude Forecast to $150: Strait of Hormuz Risks Brew, How High Can Oil Prices Rise?

Microsoft 2026 Q3 Earnings Preview: Can Azure’s Growth Momentum Keep Up With Massive AI Capital Spending?

Marvell vs. Broadcom: Who Is the More Worthy ASIC Leading Company?

Deep Analysis 48 Hours Before Microsoft Earnings: OpenAI Agreement Restructuring Implemented, Three Variables of Azure, Copilot, and Capital Expenditure Determine MSFT Valuation Recovery Path

SanDisk Earnings Preview: AI Storage Drives Performance Surge, Valuations and Risks Rise

Tradingkey







